• CDC 2026 Hantavirus Response Key Messages
  May 19, 2026
• CDC Health Advisory: Expanding Measles Outbreak in the United States and Guidance for the Upcoming Travel Season
  April 8, 2025
• Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries
  August 7, 2024
• Disruptions in Availability of Becton Dickinson (BD) BACTECTM Blood Culture Bottles
  July 23, 2024
• Severe and Fatal Confirmed Rocky Mountain Spotted Fever among People with Recent Travel to Tecate, Mexico
  December 8, 2023
• Mpox Caused by Human-to-Human Transmission of Monkeypox Virus with Geographic Spread in the Democratic Republic of the Congo
  December 7, 2023
• High Blood Lead Levels in Children Consuming Recalled Cinnamon Applesauce Pouches
  November 13, 2023
• Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season
  October 23, 2023
• Increased Respiratory Syncytial Virus (RSV) Activity in Parts of the Southeastern United States: New Prevention Tools Available to Protect Patients
  September 5, 2023
• Severe Vibrio Vulnificus Infections in the United States Associated with Warming Coastal Waters
  September 1, 2023
• Important Updates on Locally Acquired Malaria Cases Identified in Florida, Texas, and Maryland
  August 28, 2023
• Wildfire Smoke Exposure Poses Threat to At-Risk Populations
  June 30, 2023
• Locally Acquired Malaria Cases Identified in the United States
  June 27, 2023
• Guidance on Measles during the Summer Travel Season
  June 21, 2023
• Important Updates on Outbreak of Fungal Meningitis in U.S. Patients Who Underwent Surgical Procedures under Epidural Anesthesia in Matamoros, Mexico.
  June 2, 2023
• Outbreak of Suspected Fungal Meningitis in U.S. Patients who Underwent Surgical Procedures under Epidural Anesthesia in Matamoros, Mexico
  May 17, 2023
• Potential Risk for New Mpox Cases
  May 15, 2023
• Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania
  April 6, 2023
• Measles Exposure at a Large Gathering in Kentucky, February 2023 and Global Measles Outbreaks
  March 3, 2023
• Increase in Extensively Drug-Resistant Shigellosis in the United States
  February 24, 2023
• Outbreak of Extensively Drug–resistant Pseudomonas aeruginosa Associated with Artificial Tears
  February 2, 2023
• Increase in Pediatric Invasive Group A Streptococcal Infections
  December 27, 2022
• Important Updates on COVID-19 Therapeutics for Treatment and Prevention
  December 20, 2022
• Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir
  December 15, 2022
• Update on Managing Monkeypox in Patients Receiving Therapeutics
  November 18, 2022
• Update on Ebola Virus Disease (Sudan ebolavirus) Outbreak in Central Uganda
  November 7, 2022
• Increased Respiratory Virus Activity, Especially Among Children, Early in the 2022-2023 Fall and Winter
  November 4, 2022
• Outbreaks of Nontuberculous Mycobacteria Infections Highlight Importance of Maintaining and Monitoring Dental Waterlines
  October 31, 2022
• Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions
  September 29, 2022
• Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68
  September 9, 2022
• Variant Influenza Virus Infections: Recommendations for Identification, Treatment, and Prevention for Summer and Fall 2022
  August 30, 2022
• Update for Clinicians on Monkeypox in People with HIV, Children and Adolescents, and People who are Pregnant or Breastfeeding
  July 30, 2022
• Melioidosis Locally Endemic in Areas of the Mississippi Gulf Coast after Burkholderia pseudomallei Isolated in Soil and Water and Linked to Two Cases – Mississippi, 2020 and 2022
  July 27, 2022
• Recent Reports of Human Parechovirus (PeV) in the United States—2022
  July 12, 2022
• Updated Case-finding Guidance: Monkeypox Outbreak—United States, 2022
  June 14, 2022
• COVID-19 Rebound After Paxlovid Treatment
  May 24, 2022
• Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022
  May 20, 2022
• Highly Pathogenic Avian Influenza A(H5N1) Virus: Recommendations for Human Health Investigations and Response
  April 29, 2022
• Using Therapeutics to Prevent and Treat COVID-19
  December 31, 2021 (please note: the links within this document are not currently working)
• Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure
  December 24, 2021
• Update: Expansion of Recall of LeadCare Blood Lead Tests Due to Risk of Falsely Low Results
  November 5, 2021
• Source Identified and Case Definition Established: Multistate Investigation of Non-travel Associated Burkholderia pseudomallei Infections (Melioidosis) in Four Patients: Georgia, Kansas, Minnesota, and Texas – 2021
  November 3, 2021
• Expansion of Recall of LeadCare^® Blood Lead Tests Due to Risk of Falsely Low Results
  October 14, 2021
• Guidance for Clinicians Caring for Individuals Recently Evacuated from Afghanistan
  September 20, 2021
• Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events
  September 14, 2021
• Hurricane Ida — Clinical Guidance for Carbon Monoxide (CO) Poisoning
  August 30, 2021
• Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19
  August 26, 2021
• Potential Exposure to Person with Confirmed Human Monkeypox Infection — United States, 2021
  July 19, 2021
• Recall of LeadCare^® Blood Lead Tests Due to Risk of Falsely Low Results
  July 6, 2021
• Increased Interseasonal Respiratory Syncytial Virus (RSV) Activity in Parts of the Southern United States
  June 10, 2021
• Extensively Drug-Resistant Salmonella Typhi Infections Among U.S. Residents Without International Travel
  February 12, 2021
• Recent HIV Clusters and Outbreaks Across the United States Among People Who Inject Drugs and Considerations During the COVID-19 Pandemic
  October 06, 2020
• CDC Health Advisory: Serious Adverse Health Events Associated with Methanol-based Hand Sanitizers
  July 06, 2020
• CDC Health Advisory: Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates, United States, 2019–2020
  June 18, 2020
• CDC Health Update: Information and Guidance about Global Travel on Cruise Ships, Including River Cruises, due to Coronavirus Disease 2019 (COVID-19)
  March 18, 2020
• CDC Health Update: Updated Guidance on Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)
  March 08, 2020
• CDC Health Update: Update and Interim Guidance on Outbreak of Coronavirus Disease 2019 (COVID-19) and COVID-19 Hospital Preparedness Assessment Tool
  February 28, 2020
• CDC Health Update: Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) and Flowchart to Identify and Assess 2019 Novel Coronavirus
  February 03, 2020
• CDC Health Advisory: Novel Coronavirus Information Page
  January 28, 2020
• Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China
  January 21, 2020
• CDC Health Advisory: Elevated Influenza Activity: Influenza B/Victoria and A(H1N1)pdm09 Viruses are the Predominant Viruses
  January 13, 2020
• CDC Health Advisory – Outbreak of Pneumonia of Unknown Etiology (PUE) in Wuhan, China
  January 09, 2020
• CDC Health Advisory – Guidance for Using Rapid Diagnostic Tests for Ebola in the United States
  December 16, 2019
• CDC Health Advisory – Severe Pulmonary Disease Associated with Use of E-cigarettes
  August 30, 2019
• CDC Health Advisory – Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice
  June 06, 2019
• CDC Health Advisory – Influenza Season Continues with an Increase in Influenza A(H3N2) Activity
  March 28, 2019
• CDC Health Update – Widespread Outbreaks of Hepatitis A among People Who Use Drugs and People Experiencing Homelessness across the United States
  March 25, 2019
• CDC Health Advisory – Third Case of Rifampin/Penicillin-Resistant Strain of RB51 Brucella from Consuming Raw Milk
  January 23, 2019
• CDC Health Advisory – Outbreak of Life-threatening Coagulopathy Associated with Synthetic Cannabinoids Use
  December 10, 2018
• CDC Health Advisory — Hurricane Florence—Clinical Guidance for Carbon Monoxide (CO) Poisoning
  September 17, 2018
• CDC Health Advisory — Advice to Clinicians about Leptospirosis in U.S. Travelers Returning from Northern Israel
  September 07, 2018
• CDC HAN – Acute Flaccid Myelitis – CDC FAQ and HCP Job Aid
  September 05, 2018
• Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing with Non-opioids
  July 12, 2018
• Outbreak of Hepatitis A Virus (HAV) Infections among Persons Who Use Drugs and Persons Experiencing Homelessness
  June 11, 2018
• Update – CDC Recommendations for Managing and Reporting Shigella Infections with Possible Reduced Susceptibility to Ciprofloxacin
  June 07, 2018
• Outbreak of Life-threatening Coagulopathy Associated with Synthetic Cannabinoids Use
  May 25, 2018
• Seasonal Influenza A(H3N2) Activity and Antiviral Treatment of Patients with Influenza
  December 27, 2017

(702) 759-1000

Nevada Relay “Dial 711” (TTY)
After Hours & Public Health Emergencies
(702) 759-1000